ArticleBMC psychiatry2026
Study protocol of a randomized controlled trial for the effectiveness of psychomotor therapy on quality of life and psychomotor skills in depression.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06234176 (Influence of Psychomotor Therapy on Quality of Life in Patients With a Major Depressive Disorder), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Influence of Psychomotor Therapy on Quality of Life in Patients With a Major Depressive Disorder: a Randomized Controlled Trial
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPsychomotor disturbances, such as cognitive-motor and sensory deficits, are well documented in Major Depressive Disorder (MDD). Although they impact quality of life, they remain insufficiently assessed and targeted in clinical practice. Psychomotor therapy (PMT) appears promising for improving functioning and quality of life, but strong evidence from randomized controlled trials (RCT) in adults with MDD is still lacking.
methodsThis multicenter, prospective RCT aims to assess the effectiveness of a PMT on the quality of life and psychomotor functioning in adults with MDD. 128 participants diagnosed with MDD will be randomized into either the intervention group (GP) or the control group (GC). The GP will receive 12-weeks of a PMT in addition to standard care, while the GC will receive standard care with a weekly telephone follow-up. Sociodemographic, clinical, and psychomotor data will be collected at baseline and then again at 1, 3, and 6 months to serve as primary and secondary outcome measures. These data will be used to evaluate improvements in quality of life, as well as changes in depressive and anxiety symptoms, psychomotor slowing, anhedonia, self-esteem, and overall psychomotor functioning, including body image, interoception, and sensory processing. Therapeutic alliance and adherence to the PMT will also be monitored throughout the intervention. DISCUSSION: This study is the first RCT assessing the benefits of PMT on the quality of life of MDD patients. This study could justify the prescription of PMT for patients with depression and support the inclusion of psychomotor therapists in multidisciplinary teams in adult psychiatry.
trial registrationClinicalTrials.gov identifier: NCT06234176 on 2024-01-15.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.